Higher Health Care Resource Use, Costs Associated With Falls Among Older Medicare Beneficiaries on Commonly Used Insomnia Medications in the United States
By Feride Frech, PhD, MPH, Senior Director, US HEOR & RWE, Eisai Inc, and Timothy Juday, Director, US HEOR & RWE, Eisai Inc.
Feride Frech, PhD, MPH, Senior Director, US HEOR & RWE, Eisai Inc, and Timothy Juday, Director, US HEOR & RWE, Eisai Inc.
This retrospective cohort study sought to compare health care resource utilization (HCRU) and costs between elderly Medicare patients (age 65 years and older) treated with common insomnia medications and a matched control group of elderly Medicare patients (age 65 years and older) with no sleep disorders, and to estimate incremental HCRU and costs associated with falls.
